View the latest Spire Inc. (SR) stock price, news, historical charts, analyst ratings and financial information from WSJ.

AstraZeneca's first-in-class severe asthma therapy Tezspire has been approved in the EU in a new pen injector formulation suitable for administration by patients themselves.